{"id":"964d7e2e-1bcf-5e9c-b622-29674db42914","stable_key":"4d8e4781-3878-5818-8d0a-7dbd6e024555:chromium-species-bioavailability","predicate":"undergoes","statement":"Apparent absorption in the human comparison was about 0.8–1%, higher than the 0.04–0.24% range across the tested rat complexes.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"context_dependent","is_public":true,"mechanism_event_id":"4997610d-faef-562e-b64a-fc62da3f8af0","mechanism_event_label":"Absorption differed between humans and rats; the rat percentage should not be assigned directly to people.","subject":{"id":"89d5d39c-2663-5e0c-8eae-562a5b25a47d","slug":"chromium-iii-picolinate","display_name":"Chromium(III) picolinate / CrPic","entity_type_key":"chemical_species"},"object":{"id":"ac8abeb4-1398-58cc-91ca-f16e97415f15","slug":"intestinal-chromium-uptake","display_name":"Intestinal chromium uptake","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"4997610d-faef-562e-b64a-fc62da3f8af0","stable_key":"4d8e4781-3878-5818-8d0a-7dbd6e024555:chromium-species-bioavailability-event","event_type":"observed_intervention","label":"Absorption differed between humans and rats; the rat percentage should not be assigned directly to people.","description":"Apparent absorption in the human comparison was about 0.8–1%, higher than the 0.04–0.24% range across the tested rat complexes.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"00ce28d4-156b-5c29-89c6-918ce2c351d3","slug":"chromium-iii-phenylalaninate","display_name":"Chromium(III) phenylalaninate complex","entity_type_key":"chemical_species"},"role":"comparator","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"89d5d39c-2663-5e0c-8eae-562a5b25a47d","slug":"chromium-iii-picolinate","display_name":"Chromium(III) picolinate / CrPic","entity_type_key":"chemical_species"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"ac8abeb4-1398-58cc-91ca-f16e97415f15","slug":"intestinal-chromium-uptake","display_name":"Intestinal chromium uptake","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/chromium-research/22814636.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"392f4199c0cee925fff5f02ee9ce7d12047f9be5d278a55d09da0a3bb707c4b6\", \"start_char\": 0, \"end_char\": 1673, \"text_sha256\": \"392f4199c0cee925fff5f02ee9ce7d12047f9be5d278a55d09da0a3bb707c4b6\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Radiolabeled-compound whole-body counting in rats and a human volunteer","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Oral 51Cr-labeled supplement complexes; human intraindividual comparison of picolinate and phenylalaninate","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Human component was a volunteer comparison, not a large population trial. Apparent absorption, absorbed amount before early urinary loss and seven-day retention are different quantities.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Chromium research collection; topical membership is not evidence of a direct dietary effect.","comparator":null,"unit":null,"notes":"","entity":{"slug":"chromium","display_name":"Chromium","entity_type_key":"nutrient_element"}},{"dimension":"organism","value_text":"Rat and human; species-specific results retained","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Absorption differed between humans and rats; the rat percentage should not be assigned directly to people.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[chromium-p22814636] Bioavailability of chromium(III)-supplements in rats and humans. (2012). https://pubmed.ncbi.nlm.nih.gov/22814636/ DOI: 10.1007/s10534-012-9571-5","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Intestinal uptake, urine and whole-body retention","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"300be8f0-12f7-5c26-9701-72b34a9262e2","evidence_kind":"source_excerpt","locator":"Lines 133-144","start_line":133,"end_line":144,"excerpt":"### chromium-species-bioavailability\nApparent absorption in the human comparison was about 0.8–1%, higher than the 0.04–0.24% range across the tested rat complexes.\nCondition category: normal\nnutrient_topic: Chromium research collection; topical membership is not evidence of a direct dietary effect.\nplain_language: Absorption differed between humans and rats; the rat percentage should not be assigned directly to people.\norganism: Rat and human; species-specific results retained\ntissue_or_cell_type: Intestinal uptake, urine and whole-body retention\nexperimental_model: Radiolabeled-compound whole-body counting in rats and a human volunteer\nlimitations: Human component was a volunteer comparison, not a large population trial. Apparent absorption, absorbed amount before early urinary loss and seven-day retention are different quantities.\nexposure: Oral 51Cr-labeled supplement complexes; human intraindividual comparison of picolinate and phenylalaninate\nevidence_span: {\"source_cache\": \"artifacts/chromium-research/22814636.abstract.txt\", \"locator\": \"Exact primary indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"392f4199c0cee925fff5f02ee9ce7d12047f9be5d278a55d09da0a3bb707c4b6\", \"start_char\": 0, \"end_char\": 1673, \"text_sha256\": \"392f4199c0cee925fff5f02ee9ce7d12047f9be5d278a55d09da0a3bb707c4b6\"}\n[chromium-p22814636] Bioavailability of chromium(III)-supplements in rats and humans. (2012). https://pubmed.ncbi.nlm.nih.gov/22814636/ DOI: 10.1007/s10534-012-9571-5","model_system":"Radiolabeled-compound whole-body counting in rats and a human volunteer","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [chromium-p22814636] Bioavailability of chromium(III)-supplements in rats and humans. (2012). https://pubmed.ncbi.nlm.nih.gov/22814636/ DOI: 10.1007/s10534-012-9571-5","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"fa96342a-ca01-5425-98d9-d50e29bf0abd","stable_key":"import-4d8e4781-3878-5818-8d0a-7dbd6e024555","title":"Chromium: transport, insulin signaling, nutrient interactions and essentiality debate (2026-09-17)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"6cae22f9104c6de041b25c23b0fd2884cc57707ac0c9a87c20b0e665d16de5ab","revision_id":"22893798-8329-5295-9c9d-82169032fc79","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}